Home > Income Statement > MARKSANS PHARMA

MARKSANS PHARMA
Revenue

    Back to Income Statement
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹2,177 Cr₹1,852 Cr₹1,491 Cr₹1,376 Cr₹1,134 Cr

What is the latest Revenue of MARKSANS PHARMA ?

The latest Revenue ratio of MARKSANS PHARMA is ₹2,177 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹2,177 Cr
Mar2023₹1,852 Cr
Mar2022₹1,491 Cr
Mar2021₹1,376 Cr
Mar2020₹1,134 Cr

How is Revenue of MARKSANS PHARMA Trending?

Years Revenue % Change
Mar2024 ₹2,177 Cr
17.56
Mar2023 ₹1,852 Cr
24.23
Mar2022 ₹1,491 Cr
8.33
Mar2021 ₹1,376 Cr
21.33
Mar2020 ₹1,134 Cr -

Compare Revenue of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹11,746.9 Cr -1.1% -14.6% 72.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,715.0 Cr 0.3% -2.6% 36.7% Stock Analytics
DIVIS LABORATORIES ₹154,460.0 Cr -1% -0.5% 60.8% Stock Analytics
CIPLA ₹115,271.0 Cr -1.4% -3.1% 11.8% Stock Analytics
DR REDDYS LABORATORIES ₹107,511.0 Cr -3.8% -4% 15.3% Stock Analytics
ZYDUS LIFESCIENCES ₹99,189.5 Cr 0.1% 1.2% 40.3% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

-1.1%

-14.6%

72.2%

SENSEX

-0.9%

-4.3%

3.7%


You may also like the below Video Courses